#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Cardiac arrest Antithrombin III deficiency Renal cancer metastatic Fungal infection Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Bone marrow disorder Atopic keratoconjunctivitis Extranodal marginal zone B-cell lymphoma (MALT type) Acute myeloid leukaemia (in remission) Paget's disease of the vulva Neuroblastoma recurrent Vulval cancer recurrent Pancreatic carcinoma metastatic Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma Myxofibrosarcoma – Diagnostics Systemic sclerosis pulmonary – Life with Disease Cholangitis sclerosing Focal segmental glomerulosclerosis – Treatment Haemophilia B without inhibitors – Trials in Disease Lymphangioma – Trials in Disease Mast cell activation syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Splenic marginal zone lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    M2Rlab Cariprazine Copanlisib Dihydrochloride Heparin Sodium Lutetium (177Lu) Oxodotreotide Phenylbutyrate Ampicillin Ranolazine Tezepelumab Tyra-300-B01 Octreotide Acetate ALLO-QUADCAR01-T Isis 696844 Lamivudine Blu-451 Narsoplimab Inclisiran Teclistamab Mk-1942 Iptacopan Hydrochloride More therapies…

    Learn about Your Condition

    Arrhythmia supraventricular Epilepsy Arterial tortuosity syndrome Ocular hypertension Femoral neck fracture Endometrial cancer recurrent Rectal cancer Brain abscess Major depression Perineal injury Breast cancer stage IV Chronic coronary syndrome Peritoneal abscess Haematological infection End stage renal disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Hyoscine Butylbromide
    • Sodium Chloride
    • Sodium Hydrogen Carbonate
    Norway

  • Study on the Effectiveness of Ipilimumab and Nivolumab for Patients with Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on Improving Live Birth Rates in Women Under 37 with Infertility Using cpFT During ICSI

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Cpft Trifluoroacetate
    France

  • Study on the Effects of Povetacicept for Adults with IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Povetacicept
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study of Atezolizumab treatment in patients with metastatic bladder cancer (urothelial cancer) after radical cystectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    Denmark
Previous Page
1 … 30 31 32

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!